Sight Sciences (SGHT) Change in Account Payables (2020 - 2026)
Sight Sciences' quarterly Change in Account Payables came in at $143000.0 in Q1 2026, down 86.67% year-on-year from $1.1 million in Q1 2025, and up 135.93% quarter-over-quarter from -$398000.0 in Q4 2025.
Sight Sciences has reported Change in Account Payables for 7 years, with the latest figure at $143000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables fell 86.67% year-over-year to $143000.0; the trailing twelve-month figure through Mar 2026 stood at -$1.3 million (down 223.12% YoY), and the FY2025 full-year result was -$348000.0, down 203.57% from the prior year.
- Change in Account Payables for Q1 2026 stood at $143000.0, up from -$398000.0 in the prior quarter.
- The five-year high for Change in Account Payables was $1.1 million in Q1 2025, with the low at -$1.7 million in Q4 2023.
- Average Change in Account Payables over 5 years is -$85058.8, with a median of -$248000.0 recorded in 2022.
- Year-over-year, Change in Account Payables jumped 454.03% in 2023 and slumped 368.75% in 2025.
- Tracing SGHT's Change in Account Payables over 5 years: stood at -$617000.0 in 2022, then slumped by 179.42% to -$1.7 million in 2023, then jumped by 121.87% to $377000.0 in 2024, then slumped by 205.57% to -$398000.0 in 2025, then jumped by 135.93% to $143000.0 in 2026.
- The last three Change in Account Payables figures came in at $143000.0 (Q1 2026), -$398000.0 (Q4 2025), and -$335000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 56.90 Mn |
| 10 | Sight Sciences | 247.60 Mn | 162.64 Mn | 16.98 Mn | 143,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 143,000.00 |
| Mar 31, 2026 | 143,000.00 |
| Dec 31, 2025 | -398,000.00 |
| Dec 31, 2025 | -398,000.00 |
| Sep 30, 2025 | -335,000.00 |
| Sep 30, 2025 | -335,000.00 |
| Jun 30, 2025 | -688,000.00 |
| Jun 30, 2025 | -688,000.00 |
| Mar 31, 2025 | 1.07 Mn |
| Mar 31, 2025 | 1.07 Mn |
| Dec 31, 2024 | 377,000.00 |
| Dec 31, 2024 | 377,000.00 |
| Sep 30, 2024 | -668,000.00 |
| Sep 30, 2024 | -668,000.00 |
| Jun 30, 2024 | 256,000.00 |
| Jun 30, 2024 | 256,000.00 |
| Mar 31, 2024 | 371,000.00 |
| Mar 31, 2024 | 371,000.00 |
| Dec 31, 2023 | -1.72 Mn |
| Dec 31, 2023 | -1.72 Mn |
| Sep 30, 2023 | 651,000.00 |
| Sep 30, 2023 | 651,000.00 |
| Jun 30, 2023 | -688,000.00 |
| Jun 30, 2023 | -688,000.00 |
| Mar 31, 2023 | 878,000.00 |
| Mar 31, 2023 | 878,000.00 |
| Dec 31, 2022 | -617,000.00 |
| Dec 31, 2022 | -617,000.00 |
| Sep 30, 2022 | 531,000.00 |
| Sep 30, 2022 | 531,000.00 |
| Jun 30, 2022 | -360,000.00 |
| Jun 30, 2022 | -360,000.00 |
| Mar 31, 2022 | -248,000.00 |
| Mar 31, 2022 | -248,000.00 |
| Dec 31, 2021 | 1.49 Mn |
| Dec 31, 2021 | 1.49 Mn |
| Sep 30, 2021 | -1.76 Mn |
| Sep 30, 2021 | -1.76 Mn |
| Jun 30, 2021 | 367,000.00 |
| Jun 30, 2021 | 367,000.00 |
| Mar 31, 2021 | 1.07 Mn |
| Mar 31, 2021 | 1.07 Mn |
| Dec 31, 2020 | 552,000.00 |
| Dec 31, 2020 | 552,000.00 |
| Sep 30, 2020 | -856,000.00 |
| Sep 30, 2020 | -856,000.00 |